InMed Pharmaceuticals (INM) Q3 2025 Annual Earnings

Screener

Reported November 6, 2025 · Before market open

Revenue$1.1M

EPS-$0.44

Next report

Sep 23, 2026 (In 5 days)

Revenue estimate$2.1B

EPS estimate-$94.44

Versus estimates

Revenue

Q1 2026$1.3MMiss by $658.6M Q4 2025$1.1M

Q3 2025$1.1M

Q2 2025$1.8M Q1 2025$1.8M Q4 2024$772.5M

Diluted EPS

Q1 2026-$0.69Beat by $93.75 Q4 2025-$0.51

Q3 2025-$0.44

Q2 2025-$3.80 Q1 2025-$1.94 Q4 2024-$3.64

FAQ

When did InMed Pharmaceuticals report Q3 2025 earnings?: InMed Pharmaceuticals (INM) reported Q3 2025 earnings on November 6, 2025 before market open.
What were InMed Pharmaceuticals's Q3 2025 revenue and EPS?: InMed Pharmaceuticals reported revenue of $1.1M and eps of $-0.44 for Q3 2025.
How did InMed Pharmaceuticals's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 19.7% from $936.2K a year earlier and eps grew 99.2% from $-54.20.
Where can I find InMed Pharmaceuticals's Q3 2025 SEC filings?: You can read the 10-K/A periodic report (0001213900-25-102157) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment InMed Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk